H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 37 750 KRW -2.83% Market Closed
Market Cap: 1.1T KRW
Have any thoughts about
HK Inno.N Corp?
Write Note

HK Inno.N Corp
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

HK Inno.N Corp
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
HK Inno.N Corp
KOSDAQ:195940
Accrued Liabilities
â‚©53.8B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Accrued Liabilities
â‚©37.5B
CAGR 3-Years
213%
CAGR 5-Years
36%
CAGR 10-Years
48%
SK Biopharmaceuticals Co Ltd
KRX:326030
Accrued Liabilities
â‚©71.3B
CAGR 3-Years
25%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Accrued Liabilities
â‚©52.7B
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Accrued Liabilities
â‚©10.9B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Accrued Liabilities
â‚©313m
CAGR 3-Years
-47%
CAGR 5-Years
-26%
CAGR 10-Years
-17%
No Stocks Found

HK Inno.N Corp
Glance View

Market Cap
1.1T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
70 702.26 KRW
Undervaluation 47%
Intrinsic Value
Price
H

See Also

What is HK Inno.N Corp's Accrued Liabilities?
Accrued Liabilities
53.8B KRW

Based on the financial report for Dec 31, 2023, HK Inno.N Corp's Accrued Liabilities amounts to 53.8B KRW.

What is HK Inno.N Corp's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
15%

Over the last year, the Accrued Liabilities growth was 9%. The average annual Accrued Liabilities growth rates for HK Inno.N Corp have been 14% over the past three years , 15% over the past five years .

Back to Top